Intellectual Property - June 27, 2014
Orexo commences patent infringement litigation against Actavis
Orexo has filed a patent infringement action in the US District Court for the District of Delaware, against Actavis Elizabeth LLC and its parent company Actavis. The lawsuit was filed in response to an Abbreviated New Drug Application (“ANDA”) filed by Actavis. In its application, Actavis seeks to market and sell generic versions of Orexo’s patented […]
Intellectual Property - March 25, 2014
Moberg Pharma launches new patent formulation
The company will start shipping a new patent pending formulation of Kerasal Nail to customers in the US. According to Moberg Pharma the new product is shipped as a flow-through. It will be available at all existing retailers, including major drugstores CVS, Walgreens and Rite-Aid, mass retailers such as Walmart and Target as well as […]
Intellectual Property - November 13, 2013
BioInvent receives US patent for drug discovery technology
BioInvent International has announced that it has been granted a US patent for its antibody and concomitant target discovery technology F.I.R.S.T. The F.I.R.S.T. technology is a novel discovery method which allows for antibodies and disease targets to be identified simultaneously. BioInvent has used the technology successfully in several proprietary discovery projects and and offers F.I.R.S.T. […]
Intellectual Property - August 12, 2013
Pharmalundensis acquires patent
Pharmalundensis has acquired a patent application to use metabotropic glutamate receptors in group 1 for prevention of intra abdominal adhesions encountered after surgery. The project was started by Redeco Chem, a company based in Lund, south of Sweden and its collaboration partners. Pharmalundensis will during the fall of 2013 carry out further studies to evaluate the effects. Should the […]
Intellectual Property - June 17, 2013
Human genes can’t be patented
On June 13, the US Supreme Court ruled unanimously that natural human genes cannot be patented. Human genes may not be patented, but artificially copied DNA however can be claimed as intellectual property, according to the decision. The ruling concerns a challenge to patents held by biotechnology company, Myriad Genetics Inc., on two genes that […]
Intellectual Property - May 15, 2013
US Supreme Court decides on human genes patent
Can human genes be patented? This question is currently being investigated by the United States Supreme Court. The decision concerns considering a challenge to patents held by biotechnology company, Myriad Genetics Inc., on two genes that can signal if a woman faces greater risk of developing breast cancer or ovarian cancer. The Supreme Court will […]
